You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1126 to 1150 of about 5880
Next 25
02/13/2019
Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.
Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.
Oncotelic Reports that It`s Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma
02/12/2019
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
02/11/2019
Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial
02/10/2019
Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55
02/06/2019
Brain Tumor `Pied Piper` Device Gains Breakthrough Status
02/05/2019
Moleculin Biotech (MBRX) Announces FDA Orphan Drug Designation for its Brain Tumor Drug
01/31/2019
GT Medical Technologies Announces Publication of Data Showing Company’s Targeted Therapy is Effective for Treating Recurrences of Common Type of Brain Tumor
01/30/2019
Musella Foundation awards a pediatric brain tumor research grant!
01/26/2019
Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.
The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.
Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells.
Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
Effect of health disparities on overall survival of patients with glioblastoma.
01/25/2019
New Liquid Biopsy Test Detects Brain Cancer, But It Doesn`t Use Blood
01/23/2019
Regorafenib Doubles 12-Month Survival Compared with Lomustine in Recurrent GBM
01/22/2019
Dexamethasone—Friend or Foe for Patients With Glioblastoma?
01/19/2019
Activation of dopamine receptor 2 (DRD2) prompts transcriptomic and metabolic plasticity in glioblastoma.
01/18/2019
Optune Open House, Newton, MA
01/14/2019
Copay assistance program is now open!
01/11/2019
Publication Reports Role of Dopamine Receptors in Cancer and ONC201 Response
01/09/2019
Musella Foundation awards 2 grants!
ERC-USA Initiates Therapy Under Right to Try Law With First Patient In California Using Investigational Compound ERC1671 for Treatment of Glioblastoma